See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
NVIDIA Corporation (NVDA) - free report >>
Sea Limited Sponsored ADR (SE) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
NVIDIA Corporation (NVDA) - free report >>
Sea Limited Sponsored ADR (SE) - free report >>
SCANS: The FAANG of The Roaring 20s
We are just entering the roaring 20s, and it is time to readjust your portfolio for the next decade. FAANG had been the biggest tech driver for the past 10 years. Their exponential returns may be exhausted, and I think its time to look for next decade-defining equities.
When assessing “market-shifting” companies, you need to look for firms with an exciting product offering characterized by longevity and a substantial addressable market. Not to mention savvy management teams that can navigate through both the best and worst times
I have chosen my own acronym of stocks that I believe could redefine the roaring 20s: “SCANS.” This acronym includes Sea Limited (SE - Free Report) , CRISPR (CRSP - Free Report) , Alibaba (BABA - Free Report) , Nvidia (NVDA - Free Report) , and Splunk .
My article SCANS: The FAANG of the Roaring 20s gives a more detailed analysis of my pick and would make an excellent supplementary read to this video.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>